_id
69130a67ccc777a4e85d7c1a
Ticker
KLRS
Name
Kalaris Therapeutics, Inc.
Exchange
NASDAQ
Address
628 Middlefield Road, Palo Alto, CA, United States, 94301
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://kalaristx.com
Description
Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.
Last Close
8.42
Volume
94000
Current Price
9.6
Change
-0.14
Last Updated
2026-01-04T16:03:29.767Z
Image
data:image/webp;base64,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
Ipo Date
2020-07-30T00:00:00.000Z
Market Cap
45259808
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9875
Sentiment Sources
2
Rating
5
Target Price
-
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
12741000
Operating Income
-12741000
Interest Expense
0
Pretax Income
-11894000
Net Income
-11894000
Eps
-0.6359846918794797
Dividends Per Share
-
Shares Outstanding
18702400
Income Tax Expense
-
EBITDA
-11894000
Operating Margin
-
Total Other Income Expense Net
847000
Cash
42387000
Short Term Investments
34612000
Receivables
-
Inventories
-
Total Current Assets
78183000
Property Plant Equipment
1516000
Total Assets
81175000
Payables
494000
Short Term Debt
376000
Long Term Debt
-
Total Liabilities
39310000
Equity
41865000
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-9000
Cash From Operations
-11333000
Capital Expenditures
183000
Cash From Investing
-34706000
Cash From Financing
0
Net Change In Cash
-46039000
Cf_currency_symbol
USD
PE
-
PB
4.288460451451093
ROE
-28.410366654723518
ROA
-14.652294425623651
FCF
-11516000
Fcf Percent
-
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
3.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
4.5
Quality Investing Score
2
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
12741000
Quarters > 0 > income Statement > operating Income
-12741000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-11894000
Quarters > 0 > income Statement > net Income
-11894000
Quarters > 0 > income Statement > eps
-0.6359846918794797
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
18701708
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-11894000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
847000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
42387000
Quarters > 0 > balance Sheet > short Term Investments
34612000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
78183000
Quarters > 0 > balance Sheet > property Plant Equipment
1516000
Quarters > 0 > balance Sheet > total Assets
81175000
Quarters > 0 > balance Sheet > payables
494000
Quarters > 0 > balance Sheet > short Term Debt
376000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
39310000
Quarters > 0 > balance Sheet > equity
41865000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-11894000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-9000
Quarters > 0 > cash Flow > cash From Operations
-11333000
Quarters > 0 > cash Flow > capital Expenditures
183000
Quarters > 0 > cash Flow > cash From Investing
-34706000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-46039000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6359846918794797
Quarters > 0 > ratios > PB
4.288460451451093
Quarters > 0 > ratios > ROE
-28.410366654723518
Quarters > 0 > ratios > ROA
-14.652294425623651
Quarters > 0 > ratios > FCF
-11516000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
12256000
Quarters > 1 > income Statement > operating Income
-12256000
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-11350000
Quarters > 1 > income Statement > net Income
-11350000
Quarters > 1 > income Statement > eps
-0.6069101344153551
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
18701286
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-11350000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
906000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
88426000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
91651000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
92842000
Quarters > 1 > balance Sheet > payables
3680000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
39727000
Quarters > 1 > balance Sheet > equity
53115000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-11350000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-1780000
Quarters > 1 > cash Flow > cash From Operations
-14885000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2346000
Quarters > 1 > cash Flow > net Change In Cash
-12539000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.6069101344153551
Quarters > 1 > ratios > PB
3.380068635978537
Quarters > 1 > ratios > ROE
-21.36872823119646
Quarters > 1 > ratios > ROA
-12.22507054996661
Quarters > 1 > ratios > FCF
-14885000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
10354000
Quarters > 2 > income Statement > operating Income
-10354000
Quarters > 2 > income Statement > interest Expense
1443000
Quarters > 2 > income Statement > pretax Income
-10196000
Quarters > 2 > income Statement > net Income
-10196000
Quarters > 2 > income Statement > eps
-2.5155805128863054
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4053140
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-8753000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
158000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
100965000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
102182000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
103092000
Quarters > 2 > balance Sheet > payables
2374000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
39218000
Quarters > 2 > balance Sheet > equity
63874000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-10196000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
2346000
Quarters > 2 > cash Flow > cash From Operations
-7441000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
107267000
Quarters > 2 > cash Flow > net Change In Cash
99826000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.5155805128863054
Quarters > 2 > ratios > PB
0.609170304036071
Quarters > 2 > ratios > ROE
-15.962676519397565
Quarters > 2 > ratios > ROA
-9.890195165483258
Quarters > 2 > ratios > FCF
-7441000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
19524000
Quarters > 3 > income Statement > operating Income
-19524000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-18268000
Quarters > 3 > income Statement > net Income
-18268000
Quarters > 3 > income Statement > eps
-3.638884351681799
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5020220
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-18268000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
1256000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
118289000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
118546000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
118546000
Quarters > 3 > balance Sheet > payables
247000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5239000
Quarters > 3 > balance Sheet > equity
113307000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
-
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-3.638884351681799
Quarters > 3 > ratios > PB
0.4253409939368265
Quarters > 3 > ratios > ROE
-16.122569655890633
Quarters > 3 > ratios > ROA
-15.410051794240209
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
55256000
Annuals > 0 > income Statement > operating Income
-55256000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-58769000
Annuals > 0 > income Statement > net Income
-58769000
Annuals > 0 > income Statement > eps
-11.733901649582638
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5008479
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-58769000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-3513000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
118289000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
118546000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
118546000
Annuals > 0 > balance Sheet > payables
247000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5239000
Annuals > 0 > balance Sheet > equity
113307000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-58769000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-25305000
Annuals > 0 > cash Flow > cash From Operations
-67705000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
95000000
Annuals > 0 > cash Flow > cash From Financing
21000
Annuals > 0 > cash Flow > net Change In Cash
28168000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-11.733901649582638
Annuals > 0 > ratios > PB
0.36688267891657184
Annuals > 0 > ratios > ROE
-51.86705146195734
Annuals > 0 > ratios > ROA
-49.57484858198505
Annuals > 0 > ratios > FCF
-67705000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
42
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
13464000
Annuals > 1 > income Statement > operating Income
-13464000
Annuals > 1 > income Statement > interest Expense
687000
Annuals > 1 > income Statement > pretax Income
-14699000
Annuals > 1 > income Statement > net Income
-14699000
Annuals > 1 > income Statement > eps
-3.248953522657798
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4524226
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-14012000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1235000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3169000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3333000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
3333000
Annuals > 1 > balance Sheet > payables
2362000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
48350000
Annuals > 1 > balance Sheet > equity
-45017000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-14699000
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
-1092000
Annuals > 1 > cash Flow > cash From Operations
-14132000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
14242000
Annuals > 1 > cash Flow > net Change In Cash
110000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-3.248953522657798
Annuals > 1 > ratios > PB
-0.8341532265588557
Annuals > 1 > ratios > ROE
32.65210920318991
Annuals > 1 > ratios > ROA
-441.014101410141
Annuals > 1 > ratios > FCF
-14132000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
14006000
Annuals > 2 > income Statement > operating Income
-14006000
Annuals > 2 > income Statement > interest Expense
235000
Annuals > 2 > income Statement > pretax Income
-15485000
Annuals > 2 > income Statement > net Income
-15485000
Annuals > 2 > income Statement > eps
-4.646216911269409
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3332819
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-15250000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1479000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
3059000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
3899000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
3899000
Annuals > 2 > balance Sheet > payables
2759000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
3253000
Annuals > 2 > balance Sheet > total Liabilities
34171000
Annuals > 2 > balance Sheet > equity
-30272000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-15485000
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
3395000
Annuals > 2 > cash Flow > cash From Operations
-9779000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
12780000
Annuals > 2 > cash Flow > net Change In Cash
3001000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-4.646216911269409
Annuals > 2 > ratios > PB
-0.9137948500264271
Annuals > 2 > ratios > ROE
51.15288054968288
Annuals > 2 > ratios > ROA
-397.1531161836368
Annuals > 2 > ratios > FCF
-9779000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
1117000
Annuals > 3 > income Statement > gross Profit
-1117000
Annuals > 3 > income Statement > operating Expenses
168701000
Annuals > 3 > income Statement > operating Income
-169818000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-170955000
Annuals > 3 > income Statement > net Income
-171962000
Annuals > 3 > income Statement > eps
-62.997658680193155
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2729657
Annuals > 3 > income Statement > income Tax Expense
1006999
Annuals > 3 > income Statement > EBITDA
-169838000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1137000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
201661000
Annuals > 3 > balance Sheet > short Term Investments
46459000
Annuals > 3 > balance Sheet > receivables
50000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
253348000
Annuals > 3 > balance Sheet > property Plant Equipment
31292000
Annuals > 3 > balance Sheet > total Assets
286594000
Annuals > 3 > balance Sheet > payables
8361000
Annuals > 3 > balance Sheet > short Term Debt
6591000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
61328000
Annuals > 3 > balance Sheet > equity
225266000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-171962000
Annuals > 3 > cash Flow > depreciation
1117000
Annuals > 3 > cash Flow > change In Working Capital
19354000
Annuals > 3 > cash Flow > cash From Operations
-106319000
Annuals > 3 > cash Flow > capital Expenditures
26000
Annuals > 3 > cash Flow > cash From Investing
185983000
Annuals > 3 > cash Flow > cash From Financing
232000
Annuals > 3 > cash Flow > net Change In Cash
79000000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-62.997658680193155
Annuals > 3 > ratios > PB
0.10057511164578765
Annuals > 3 > ratios > ROE
-76.3373078937789
Annuals > 3 > ratios > ROA
-60.00195398368423
Annuals > 3 > ratios > FCF
-106345000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
41
Valuation > metrics > PE
-0.6359846918794797
Valuation > metrics > PB
4.288460451451093
Valuation > final Score
37.11539548548907
Valuation > verdict
42.9% Overvalued
Profitability > metrics > ROE
-28.410366654723518
Profitability > metrics > ROA
-15.213025849609249
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9389705004180102
Risk > final Score
68
Risk > verdict
High
Liquidity > metrics > Current Ratio
89.86551724137931
Liquidity > metrics > Quick Ratio
89.86551724137931
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
46.199313640214626
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
68
Prev Risks > 1
19
Prev Risks > 2
80
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:05:57.800Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.64
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.61
Earnings History > 1 > eps Estimate
-0.62
Earnings History > 1 > eps Difference
0.01
Earnings History > 1 > surprise Percent
1.6129
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-2.52
Earnings History > 2 > eps Estimate
-0.77
Earnings History > 2 > eps Difference
-1.75
Earnings History > 2 > surprise Percent
-227.2727
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-12
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-3.28
Earnings History > 3 > eps Estimate
-0.12
Earnings History > 3 > eps Difference
-3.16
Earnings History > 3 > surprise Percent
-2633.3333
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-29
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.8223
Earnings History > 4 > eps Estimate
-0.095
Earnings History > 4 > eps Difference
-0.7273
Earnings History > 4 > surprise Percent
-765.5789
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.05
Earnings History > 5 > eps Estimate
-0.05
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-02
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.26
Earnings History > 6 > eps Estimate
-0.26
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-08
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.52
Earnings History > 7 > eps Estimate
-0.52
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.39
Earnings History > 8 > eps Estimate
-0.39
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.48
Earnings History > 9 > eps Estimate
-0.48
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.44
Earnings History > 10 > eps Estimate
-0.47
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
6.383
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-15
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.32
Earnings History > 11 > eps Estimate
-0.32
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.5
Earnings History > 12 > eps Estimate
-0.5
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.69
Earnings History > 13 > eps Estimate
-0.69
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.69
Earnings History > 14 > eps Estimate
-0.69
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.92
Earnings History > 15 > eps Estimate
-0.92
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-05
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.72
Earnings History > 16 > eps Estimate
-0.72
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-06
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.6
Earnings History > 17 > eps Estimate
-0.6
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.5
Earnings History > 18 > eps Estimate
-0.5
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.41
Earnings History > 19 > eps Estimate
-0.44
Earnings History > 19 > eps Difference
0.03
Earnings History > 19 > surprise Percent
6.8182
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.58
Earnings History > 20 > eps Estimate
-0.58
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-07-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.34
Earnings History > 21 > eps Estimate
-4.43
Earnings History > 21 > eps Difference
4.09
Earnings History > 21 > surprise Percent
92.3251
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-03
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-4.21
Earnings History > 22 > eps Estimate
-0.2
Earnings History > 22 > eps Difference
-4.01
Earnings History > 22 > surprise Percent
-2005
Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWill PEB.PRE stock gain from lower inflation - July 2025 Opening Moves & Low Volatility Stock Suggestions bollywoodhelpline.com
Read more →Retail Trends: Can KLRS deliver consistent dividends - New Guidance & Fast Moving Stock Watchlists baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
$
Analyst Picks
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Kalaris Therapeutics, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.64
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.